Gil Blum
Stock Analyst at Needham
(3.06)
# 1,324
Out of 4,966 analysts
411
Total ratings
38.21%
Success rate
2.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $74 → $70 | $51.23 | +36.64% | 19 | Aug 15, 2025 | |
| NKTX Nkarta | Reiterates: Buy | $10 | $2.12 | +371.70% | 18 | Aug 13, 2025 | |
| ABSI Absci | Maintains: Buy | $9 → $8 | $2.39 | +234.73% | 5 | Aug 13, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.50 | +566.67% | 29 | Jul 21, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $51.83 | +56.28% | 24 | Jul 8, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $3.15 | +471.43% | 6 | May 15, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $69.39 | +51.32% | 23 | Dec 10, 2024 | |
| IMAB I-Mab | Maintains: Buy | $5 → $6 | $4.16 | +44.23% | 16 | Aug 20, 2025 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $15 | $6.00 | +150.00% | 18 | Aug 13, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Underperform | n/a | $18.20 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.28 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $5 | $1.71 | +192.40% | 19 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.70 | +70.21% | 24 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.92 | +173.97% | 29 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.04 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $10.05 | +298.01% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $9.34 | +189.08% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $32.22 | +120.36% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.80 | +400.00% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.98 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.40 | +257.14% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.59 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $5.03 | +854.27% | 9 | Aug 2, 2024 |
Celcuity
Aug 15, 2025
Maintains: Buy
Price Target: $74 → $70
Current: $51.23
Upside: +36.64%
Nkarta
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.12
Upside: +371.70%
Absci
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.39
Upside: +234.73%
Autolus Therapeutics
Jul 21, 2025
Reiterates: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
CRISPR Therapeutics AG
Jul 8, 2025
Reiterates: Buy
Price Target: $81
Current: $51.83
Upside: +56.28%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $3.15
Upside: +471.43%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $69.39
Upside: +51.32%
I-Mab
Aug 20, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $4.16
Upside: +44.23%
Generation Bio Co.
Aug 13, 2025
Reiterates: Buy
Price Target: $15
Current: $6.00
Upside: +150.00%
Sarepta Therapeutics
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $18.20
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.28
Upside: -
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $1.71
Upside: +192.40%
Jul 8, 2025
Reiterates: Buy
Price Target: $8
Current: $4.70
Upside: +70.21%
Jul 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.92
Upside: +173.97%
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.04
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $10.05
Upside: +298.01%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $9.34
Upside: +189.08%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $32.22
Upside: +120.36%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.80
Upside: +400.00%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.98
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.59
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $5.03
Upside: +854.27%